Beneficial effect of renal transplantation on cognitive brain function

Kidney International

Volumn 49, Issue 3, 1996, Pages 833-838

  Kramer, Ludwig ^a,c   Madl, Christian ^a   Stockenhuber, Felix ^a   Yeganehfar, Wafa ^a   Eisenhuber, Edith ^a   Derfler, Kurt ^a   Lenz, Kurt ^a   Schneider, Barbara ^a   Grimm, Georg ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b GENERAL HOSPITAL KLAGENFURT   (Austria)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN;

ADULT; ARTICLE; BRAIN FUNCTION; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; EVOKED RESPONSE; FEMALE; GRAFT REJECTION; HEMODIALYSIS; HUMAN; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL; PSYCHOMETRY;

EID: 0029885689     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.115     Document Type: Article

References (55)

1. TESCHAN PE, ARIEFF AI: Uremic and dialysis encephalopathies, in Cerebral Energy Metabolism and Metabolic Encephalopathies, edited by MCCANDLESS DW, New York, Plenum Press, 1985, pp 263-286
2. RASKIN NH, FISHMAN RA: Neurological disorders in renal failure. N Engl J Med 294:143-148, 204-210, 1979
3. ENGLISH A, SAVAGE RD, BRITTON PG, WARD MK, KERR DNS: Intellectual impairment in chronic renal failure. Br Med J 1:888-890, 1978
4. FRASER CL, ARIEFF AI: Nervous system complications in uremia. Ann Int Med 109:143-153, 1988
5. TESCHAN PE, GINN HE, BOURNE JR, WARD JB, HAMEL B, NUNNALLY JC, MUSSO N, VAUGHN WK: Quantitative indices of clinical uremia. Kidney Int 15:676-697, 1979
6. ALFREY AC: Dialysis encephalopathy. Kidney Int 29(Suppl 18):S53-S57, 1986
7. BROWN WS, MARSH JT, WOLCOTT D, TAKUSHI R, CARR CR, HIGA J, NISSENSON AR: Cognitive function, mood and P3 latency: Effects of the amelioration of anemia in dialysis patients. Neuropsychologia 29:35-45, 1991
8. WOLCOTT DL, WELLISCH DK, MARSH JT, SCHAEFFER J, NISSENSON AR: Relationship of dialysis modality and other factors to cognitive function in chronic hemodialysis patients. Am J Kidney Dis 12:275-284, 1988
9. COHEN SN, SYNDULKO K, REVER B, KRAUT J, COBURN J, TOURTELLOTTE WW: Visual evoked potentials and long latency event-related potentials in chronic renal failure. Neurology 33:1219-1222, 1983
10. LEWIS EG, DUSTMAN RE, BECK EC: Visual and somatosensory evoked potentials characteristics of patients undergoing hemodialysis and kidney transplantation. Electroenceph Clin Neurophysiol 44:223-231, 1978
11. PAGANI C, BAZZI C, ARRIGO G, VENTURINI CT, D'AMICO G: Evoked potentials (VEPs and BAEPs) in a large cohort of short- and long-term hemodialysis patients. Nephrol Dial Transplant 8:1124-1128, 1993
12. ROZEMAN CAM, JONKMAN EJ, POORTVLIET DCJ, EMMMEN HH, DE WEERD AW, VAN DER MAAS APC, TJNDRA YI, BEERMAN EM: Encephalopathy in patients on continuous ambulatory peritoneal dialysis and patients on chronic hemodialysis. Nephrol Dial Transplant 7:1213-1218, 1992
13. GRIMM G, STOCKENHUBER F, SCHNEEWEISS B, MADL C, ZEITLHOFER J, SCHNEIDER B: Improvement of brain function in hemodialysis patients treated with erythropoietin. Kidney Int 38:480-486, 1990
14. MARSH JT, BROWN WS, WOLCOTT D, CARR CR, HARPER R, SCHWEITZER SV, NISSENSON AR: rHuEPO treatment improves brain and cognitive function of anemic dialysis patients. Kidney Int 39:155-163, 1991
15. WOLCOTT DL, MARSH JT, LA RUE A, CARR C, NISSENSON AR: Recombinant human erythropoietin treatment may improve quality of life and cognitive function in chronic hemodialysis patients. Am J Kidney Dis 14:478-485, 1989
16. SAGALÉS T, GIMENO V, PLANELLA MJ, RAGUER N, BARTOLOME J: Effects of rHuEPO on Q-EEG and event-related potentials in chronic renal failure. Kidney Int 44:1109-1115, 1993
17. MAYER G, THUM J, CADA EM, STUMMVOLL HK, GRAF H: Working capacity is increased following recombinant human erythropoietin treatment. Kidney Int 34:525-528, 1988
18. MCMAHON LP, DAWBORN JK: Subjective quality of life assessment in hemodialysis patients at different levels of hemoglobin following use of rHuEPO. Am J Nephrol 12:162-169, 1992
19. ESCHBACH JW: Erythropoietin: The promise and the facts. Kidney Int 45(Suppl 44):S70-S76, 1994
20. HEGBRANT J, THYSELL H, EKMAN R: Erythropoietin treatment and plasma levels of corticotropin-releasing hormone, delta sleep-inducing peptide and opioid peptides in hemodialysis patients. Scand J Urol Nephrol 26:393-396, 1992
21. BESARAB A, CARO J, JARRELL BE, FRANCOS G, ERSLEV AJ: Dynamics of erythropoiesis following renal transplantation. Kidney Int 32:526-536, 1987
22. MILLER DG, LEVINE SE, D'ELIA JA, BISTRIAN BR: Nutritional status of diabetic and nondiabetic patients after renal transplantation. Am J Clin Nutr 44:66-69, 1986
23. RUSSSEL JD, BEECROFT ML, LUDWIN D, CHURCHILL DN: The quality of life in renal transplantation - A prospective study. Transplantation 54:656-660, 1992
24. EWANS RW, MANNINEN DL, GARRISON LP, HART LG, BLAGG, GR, GUTMAN RA, HULL AR, LOWRIE EG: The quality of life of patients with renal failure. N Engl J Med 312:553-559, 1985
25. MORRIS PL, JONES B: Transplantation versus dialysis: A study of quality of life. Transplant Proc 20:23-26, 1988
26. GOKAL R: Quality of life in patients undergoing renal replacement therapy. Kidney Int 43(Suppl 40):S23-S27, 1993
27. BROWN JJ, SUFIT RL, SOLLINGER HW: Visual evoked potential changes following renal transplantation. Electroenceph Clin Neurophysiol 66:101-110, 1987
28. KUBA M, PEREGRIN J, VIT F, HANUSOVA I, ERBEN J: Pattern-reversal visual evoked potentials in patients with chronic renal insufficiency. Electroenceph Clin Neurophysiol 6:438-442, 1983
29. YU YL, CHENG IKP, CHANG CM, BRUCE IC, MOK KY, ZHONG WY, CHAN YW: A multimodal neurophysiological assessment in terminal renal failure. Acta Neurol Scand 83:89-95, 1991
30. GRIMM G, PRAYER L, ODER W, FERENCI P, MADL C, KNOFLACH P, SCHNEIDER B, IMHOF H, GANGI. A: Comparison of functional and structural brain disturbances in Wilson's disease. Neurology 41:272-276, 1991
31. GRIMM G, ODER W, PRAYER L, FERENCI P, MADL C: Evoked potentials in assessment and follow-up of patients with Wilson's disease. Lancet 336:963-964, 1990
32. MADL C, GRIMM G, KRAMER L, YEGANEHFAR W, STERZ F. SCHNEIDER B, KRANZ A, SCHNEEWEISS B, LENZ K: Early prediction of individual outcome following cardiopulmonary resuscitation. Lancet 341:855-858, 1993
33. MADL C, GRIMM G, KRAMER L, FERENCI F, YEGANEHFAR W, LENZ K: Serial recording of sensory evoked potentials - A noninvasive prognostic indicator in fulminant hepatic failure. Hepatology 20:1487-1497, 1994
34. PICTON TW: The P300 wave of the human event-related potential. J Clin Neurophysiol 9:456-479, 1992
35. DAVIES MG, ROWAN MJ, MACMATHUNA P, KEELING PWN, WEIR DG, FEELY J: The auditory event-related potential: An objective marker of the encephalopathy of chronic liver disease. Hepatology 12:688-694, 1990
36. DE FEO P, GALLAI V, MAZZOTTA G, CRISPINO G, TOLONE E, PERRIELLO G, VENTURA MM, SANTEUSANIO F, BRUNETTI P, BOLLI GB: Modest decrement in plasma glucose concentration causes early impairment in cognitive function and later activation of glucose counterregulation in the absence of hypoglycemic symptoms in normal man. J Clin Invest 82:436-444, 1988
37. POLICH J, HOWARD L, STARR A: Effects of age on the P300 component of the event-related potential from auditory stimuli: Peak definition, variation, and measurement. J Gerontol 40:721-726, 1985
38. GOODIN DS, AMINOFF MJ: Electrophysiological differences between subtypes of dementia. Brain 109:1103-1113, 1986
39. BARIBEAU-BRAÜN J, PICTON TW, GOSSELIN JY: Schizophrenia: A neurophysiological evaluation of abnormal information processing. Science 219:874-876, 1983
40. KNIGHT RT: Neuronal mechanisms of event-related potentials: evidence from human lesion studies, in Event Related Brain Potentials: Basic Issues and Applications, edited by ROHRBAUGH JW, PARASURAMAN R, JOHNSON R, New York, Oxford University Press, 1990, pp 3-18
41. HONIG LS, RAMSAY E, SHEREMATA WA: Event-related potential P300 in multiple sclerosis. Arch Neurol 49:44-59, 1992
42. MADL C, GRIMM G, KRAMER L, YEGANEHFAR W, KOPPENSTEINER R, HIRSCHL M, HIRSCHL MM, UGURLUOGLU A, EHRINGER H: Cognitive brain function in non-demented patients with low-grade and high-grade carotid artery stenosis. Eur J Clin Invest 24:559-564, 1994
43. NISSENSON AR, NIMER SD, WOLCOTT DL: Recombinant human erythropoietin and renal anemia: Molecular biology, clinical efficacy, and nervous system effects. Ann Intern Med 114:402-416, 1991
44. JASPER HH: The ten/twenty electrode system of the International Federation. Electroenceph Clin Neurophys 10:371-375, 1958
45. REITAN RM, WOLFSON D: The Halstead - Reitan neuropsycological test battery. Tucson: Neuropsychology Press 1985
46. FOLSTEIN MF, FOLSTEIN SE, MCHUGH PR: "Mini-Mental State": A practical method for grading the cognitive state of patients for the clinician. J Psychiat Res 12:189-198, 1975
47. BOLTON CF: Electrophysiologic changes in uremic neuropathy after successful renal transplantation. Neurology 26:152-161, 1976
48. JOHANSSON U, ANDERSSON T, PERSSON A, ERIKSSON LS: Visual evoked potentials - A tool in the diagnosis of hepatic encephalopathy? J Hepatology 9:227-233, 1989
49. KEMPEN JH, KRICHEVSKY M, FELDMAN ST: Effects of visual impairment on neuropsychological test performance. J Clin Exp Neuropsychol 16:223-231, 1994
50. NISSENSON AR: Epoetin and cognitive function. Am J Kidney Dis 20(Suppl 1):S21-S24, 1991
51. HIRAKATA H, YAO H, OSATO S, IBAYASHI S, ONOYAMA K, OTSUKA M, ICHIYA Y, KUWABARA Y, MASUDA Y, FUJISHIMA M: CBF and oxygen metabolism in hemodialysis patients: Effects of anemia correction with recombinant human EPO. Am J Physiol 262:F737-F747, 1992
52. PALMER BF, TOTO RD: Severe neurologic toxicity induced by cyclosporine A in three renal transplant patients. Am J Kidney Dis 18:116-121, 1991
53. LUKE RG: Hypertension in renal transplant recipients. Kidney Int 31:1024-1037, 1987
54. RUBIN RH: Infectious disease complications of renal transplantation. Kidney Int 44:221-236, 1993
55. FIRST MR: Long-term complications after transplantation. Am J Kidney Dis 22:477-486, 1993